Elevance Health, Inc. will release its Q1 2025 financial results on April 22, 2025, expecting GAAP net income of $9.61 per diluted share, with adjusted income at $11.97 per diluted share, and reaffirming full-year guidance of $34.15 to $34.85 per diluted share.